You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MGUS

Showing 26 - 50 of 94
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Roma, Rome (ChIP-seq, NGS, ATAC-seq)

Recruiting
  • Multiple Myeloma
  • ChIP-seq, NGS, ATAC-seq
  • Roma, Italy
  • +1 more
May 24, 2023

Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

Not yet recruiting
  • Monoclonal Gammopathy of Uncertain Significance
  • Zanubrutinib Oral Product
  • Utrecht, Netherlands
    University Medical Center Utrecht
Jul 6, 2023

Multiple Myeloma Trial in Houston (TAA-specific CTLs, TAA-specific CTLs- fixed dose)

Recruiting
  • Multiple Myeloma
  • TAA-specific CTLs
  • TAA-specific CTLs- fixed dose
  • Houston, Texas
    Houston Methodist Hospital
Nov 11, 2022

Monoclonal Gammopathy of Undetermined Significance Trial in Reykjavík (Clinical follow-up 1, Mental Health and Quality of Life

Active, not recruiting
  • Monoclonal Gammopathy of Undetermined Significance
  • Clinical follow-up 1
  • +5 more
  • Reykjavík, Iceland
    University of Iceland
Feb 28, 2022

Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Metformin XR, Placebo)

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Multiple Myeloma
  • Metformin XR
  • Placebo
  • Boston, Massachusetts
  • +6 more
Oct 3, 2022

Screening to Improve Survival in AL Amyloidosis

Recruiting
  • Smoldering Multiple Myeloma
  • Monoclonal Gammopathy of Undetermined Significance
    • Orange, California
    • +5 more
    Nov 16, 2022

    Developing Myeloma in a High-Risk Screened Population (PROMISE)

    Recruiting
    • Multiple Myeloma
    • Sample of Blood
    • Baltimore, Maryland
    • +2 more
    Mar 22, 2022

    Hematological Malignancies - SANGUINE

    Recruiting
    • Hematologic Malignancy
    • Blood sampling for HemaChip screening/diagnostic testing
    • Bone marrow sampling
    • Olomouc, Czechia
    • +3 more
    Feb 9, 2023

    Sleep Apnea in Patients With MGUS and MM

    Recruiting
    • Multiple Myeloma
    • Monoclonal Gammopathy of Undetermined Significance
    • Bone Marrow Aspirate and Biopsy
    • Iowa City, Iowa
      University of Iowa
    Oct 1, 2019

    MDS, Ferroptosis Trial in Pessac (Biological sampling)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Ferroptosis
    • Biological sampling
    • Pessac, France
    • +2 more
    Jun 19, 2023

    Dysglobulinemia Trial in France (Genetic analysis of peripheral blood samples)

    Recruiting
    • Dysglobulinemia
    • Genetic analysis of peripheral blood samples
    • POINTE-à-PITRE, Guadeloupe, France
    • +46 more
    Mar 21, 2022

    Questionnaire and Tissue Banking For Multiple Myeloma,

    Active, not recruiting
    • Multiple Myeloma
    • +3 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Mar 15, 2022

      Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple

      Not yet recruiting
      • Multiple Myeloma
      • +2 more
      • Multiple Myeloma M-Protein Analysis
      • Multiple Myeloma Knowledge Questionnaires
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
      Apr 26, 2023

      Non-Hodgkin Lymphoma, Multiple Myeloma Trial in New York ([68Ga]-Pentixafor)

      Recruiting
      • Non-Hodgkin Lymphoma
      • Multiple Myeloma
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      May 4, 2022

      Two Biologically and Clinically Distinct Entities: Progressive

      Recruiting
      • Multiple Myeloma
      • +2 more
        • Miami, Florida
          University of Miami Hospitals
        Jun 7, 2022

        Quality of Life in Asymptomatic Monoclonal Gammopathies

        Recruiting
        • Monoclonal Gammopathy of Undetermined Significance
        • Smoldering Plasma Cell Myeloma
        • Quality-of-Life Assessment
        • Questionnaire Administration
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 25, 2022

        Smoldering Multiple Myeloma Trial (Selinexor)

        Not yet recruiting
        • Smoldering Multiple Myeloma
        • (no location specified)
        Oct 27, 2022

        Amyloidosis, Transthyretin Amyloidosis Trial in Portland (124I-Evuzamitide)

        Recruiting
        • Amyloidosis
        • Transthyretin Amyloidosis
        • 124I-Evuzamitide
        • Portland, Oregon
          Oregon Health & Science University
        Feb 24, 2023

        Monoclonal Gammopathy Trial in New York, Philadelphia (Isatuximab)

        Recruiting
        • Monoclonal Gammopathy
        • Boston, Massachusetts
        • +1 more
        Nov 16, 2022

        Acid Sphingomyelinase Deficiency Disease and Gaucher Disease in

        Recruiting
        • Gaucher Disease
        • Acid SphingoMyelinase Deficiency
          • Ponferrada, León, Spain
          • +11 more
          Aug 8, 2023

          Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

          Enrolling by invitation
          • Monoclonal Gammopathy of Undetermined Significance
          • +6 more
            • Milwaukee, Wisconsin
              Aurora Health Care
            Jul 20, 2021

            CHIP/CCUS Natural History Protocol

            Recruiting
            • Clonal Hematopoiesis of Indeterminate Potential
            • Clonal Cytopenia of Undetermined Significance
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Aug 20, 2022

              Multiple Myeloma Trial in Austria, Germany, Israel (Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA], Placebo 1.7 ml

              Active, not recruiting
              • Multiple Myeloma
              • Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]
              • Placebo 1.7 ml Subcutaneous Solution
              • Graz, Austria
              • +9 more
              Aug 24, 2022

              Influenza, Multiple Myeloma, Waldenstrom's Macroglobulinemia Trial in New Haven (Fluzone High Dose Vaccine, Standard of

              Completed
              Has Results
              • Influenza
              • +4 more
              • Fluzone High Dose Vaccine
              • Standard of care/Placebo
              • New Haven, Connecticut
                Yale University
              Jan 28, 2019

              Neuropathy, Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS) Trial in Lebanon (Lenalidomide)

              Terminated
              Has Results
              • Neuropathy
              • Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)
              • Lebanon, New Hampshire
                Dartmouth-Hitchcock Medical Center
              Sep 7, 2018